Company intelligence / Profile preview

Pangea Phytoceuticals

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Pangea Botanica is a biotechnology company dedicated to the discovery and development of nature-inspired medicines, specifically focusing on 'phytoceuticals.' By leveraging its proprietary AI-driven platform, Pangea Phyto, the company identifies and optimizes bioactive compounds from plants to address unmet medical needs in neurology, psychiatry, and immunology. Pangea aims to modernize traditional herbal medicine by applying rigorous pharmaceutical standards, including clinical validation and standardized manufacturing. The company's approach combines ethnobotanical knowledge with advanced computational chemistry to accelerate the drug discovery process.

Therapeutic areas: ImmunologyPsychiatryNeurology
Modalities: Small moleculePhytoceuticals
Industry: Biotech

Beyond the preview

Go deeper on Pangea Phytoceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pangea Phytoceuticals.

Explore the full profile